Alphabet's GV Leads Funding in Gene Editing Company Verve Therapeutics

  1. Home
  2. Blog

Posted on Tue May 7 2019 | 11:09 pm

GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.

Read More →


Search
Categories
Side Widget
You can put anything you want inside of these side widgets. They are easy to use, and feature the new Bootstrap 4 card containers!